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Oxyopinins (Oxki1 and Oxki2) are antimicrobial peptides isolated from the crude venom of the wolf spider Oxyopes kitabensis. The effect of
oxyopinins on lipid bilayers was investigated using high-sensitivity titration calorimetry and 31P solid-state NMR spectroscopy. High-sensitivity
titration calorimetry experiments showed that the binding of oxyopinins was exothermic, and the binding enthalpies (ΔH) to 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphatidylcholine (POPC) small unilamellar vesicles (SUVs) were −18.1 kcal/mol and −15.0 kcal/mol for Oxki1 and Oxki2,
respectively, and peptide partition coefficient (Kp) was found to be 3.9×10
3 M−1. 31P NMR spectra of 1,2-dielaidoyl-sn-glycero-3-phospho-
ethanolamine (DEPE) membranes in the presence of oxyopinins indicated that they induced a positive curvature in lipid bilayers. The induced
positive curvature was stronger in the presence of Oxki2 than in the presence of Oxki1. 31P NMR spectra of phosphaditylcholine (PC) membranes in
the presence of Oxki2 showed that Oxki2 produced micellization of membranes at low peptide concentrations, but unsaturated PC membranes or
acidic phospholipids prevented micellization from occurring. Furthermore, 31P NMR spectra using membrane lipids from E. coli suggested that
Oxki1 was more disruptive to bacterial membranes than Oxki2. These results strongly correlate to the known biological activity of the oxyopinins.
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Polycationic antimicrobial peptides represent the chemical
counterpart to the cell-mediated immune response in the innate
host defense against pathogenic microorganisms [1,2]. They act
as self-defense against other animals or pathogens or as wea-
pons for capturing prey by forming channels or pores in the cellAbbreviations: CD, circular dichroism; DMPC, 1,2-dimyristoyl-sn-glycero-
3-phosphatidylcholine; DMPG, 1,2-dimyristoyl-sn-glycero-3-phosphatidylgly-
cerol; DEPE, 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine; HII, inverted
hexagonal phase; HPLC, high-performance liquid chromatography; ITC,
isothermal titration calorimetry; Lα, lamellar phase; MALDI-TOF, matrix-
assisted laser-desorption ionization-time-of-flight; MLV, multi-lamellar vesicles;
NMR, nuclearmagnetic resonance; ODS, octa decyl silica; PC, phosphaditylcho-
line; PE, phosphaditylethanolamine; PG, phosphatidylglycerol; POPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine; POPG, 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphatidylglycerol; SUVs, small unilamellar vesicles
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doi:10.1016/j.bbamem.2006.04.022membrane, including cell permeation and a breakdown of cel-
lular physiology. They have been found in various organisms,
for example, PGLA [1] and magainin 2 [2] in the skin of frog,
buforins [3] in the stomach tissue of toad, cecropin A [4], melit-
tin [5], mastoparan X [6], ponericin [7], and pandinins [8] in
venomous secretions of insects and scorpion, polyphemusins
and tachyplesins [9] in the hemocyte of horse shoe crab, LL-37
[10] in the epithelial cell of human, and paradaxin [11] in mu-
cosal secretion of fish. There are also newly designed antimicro-
bial peptides, for example, MSI-78 and (KIGAKI)3 [12], that
have stronger activity than naturally occurring ones for pharma-
ceutical development. These types of antimicrobial peptides are
relatively small (2–6 kDa), amphipathic and basic peptides of
variable length, sequence and structure. These peptides have
been separated into two main categories according to whether or
not they contain cysteines linked in disulfide bridges: (1) linear
α-helical peptides, which adopt a random structure in dilute
aqueous solution and form α-helices or an helix–bend–helix
motif in organic solvents and upon contact with cell membrane
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comprise the α- and β-defensins, and the protegrin/tachyplesin
group, which contain several disulfide bridges and adopt either a
β-sheet or a β-hairpin fold [9]. The number of antimicrobial
peptides described so far has increased considerably to more than
800, of which roughly more than half are linearα-helical peptides
(http://www.bbcm.univ.trieste.it/~tossi/pag5.htm). Several mech-
anisms of membrane disruption have been proposed for antimi-
crobial peptides [13–26]. For example, melittin and pandinin2
insert into the membrane hydrophobic core with their average
helical axis perpendicular to the membrane surface and rotate
around the membrane normal [13–15]. Cecropin A and pandinin
1 lie at the surface of the bilayer and self-associates in a “carpet-
like” manner [16,17]. Magainin2 and mastoparan X forms “to-
roidal pores” in lipid bilayers, where the inner and outer mono-
layers are associated via phospholipid lining, and the pores are
formed by the lipid polar head groups and helix polar face [18,19].
Oxyopinins are large cationic peptides isolated from the crude
venom of the wolf spider Oxyopes kitabensis [27]. Oxyopinin 1
(Oxki1) and Oxyopinin 2 (Oxki2) are composed of 48 and 37
residues, respectively. As shown by their helical wheel repre-
sentations (Fig. 1), both oxyopinins are amphipathic and cationic
peptides that have demonstrated high antimicrobial activity
against a range of Gram-positive and Gram-negative bacteria.
Although they have been chemically and biologically character-
ized, the binding and membrane disrupting mechanisms of the
oxyopinins in lipid membranes have not yet been clarified.
In this study, we investigated the binding of oxyopinins to
lipid membranes using 31P solid-state NMR spectroscopy. Fur-
thermore, we used CD spectroscopy and high-sensitivity titra-
tion calorimetry to investigate the binding of Oxki1 and Oxki2
to unilamellar phospholipid vesicles.
2. Materials and methods
2.1. Materials
Phospholipids, including the lipids from E. colimembranes, were purchased
from Funakoshi (Tokyo, Japan) and used without further purification. The pep-
tides Oxki1 and Oxki2 were chemically synthesized by solid-phase peptide
synthesis using fluoren-9-ylmethoxycarbonyl (Fmoc) methodology on an Ap-
plied Biosystems 433A peptide synthesizer. Fmoc-Gln(tBu)-PEG resin (Wata-Fig. 1. (a) Amino acid sequences of Oxki1 and Oxki2. (b)Helical wheel projections
black, white, and gray, respectively.nabe Ltd., Hiroshima, Japan) was used for Oxki1 and Oxki2 to provide a free
carboxyl group at the C-terminus. After synthesis, peptide deprotection, and
cleavage from the resin, the crude peptides were dissolved in 30% acetonitrile
solution and purified by reversed-phase HPLC on a semi-preparative C18 ODS
column (10×250 mm, Nacalai Tesque, Kyoto, Japan). Cation exchange chroma-
tography and C4 reversed-phase HPLC were further used to purify the peptides.
The mass and purity of the peptides were confirmed by MALDI-TOF-MS.
2.2. Preparation of phospholipids vesicles
Small unilamellar vesicles (SUVs) for CD and ITC measurements were
prepared as follows. A defined amount of lipid was dissolved in chloroform and
dried first under nitrogen and then overnight under high vacuum. The lipid film
was hydrated with 20 mM Tris buffer (100 mM NaCl, pH 7.6), and the lipid
suspension was extensively vortex-mixed. Finally, the lipid dispersions were
sonicated in ice water for 10 min using the titanium tip ultrasonicator until the
solution became opalescent.
Multi-lamellar vesicles (MLVs) for NMR measurements were prepared as
follows. The membrane system was made up of lipids and co-solubilized with
the appropriate amounts of peptide to give the desired peptide-to-lipid (P/L)
molar ratio in chloroform/methanol (2:1). After solvent evaporation under high
vacuum overnight, the lipid film was hydrated with 20 mM Tris buffer (100 mM
NaCl, pH 7.6), and the suspension was vortex-mixed extensively. The suspen-
sion was freeze-thawed for ten cycles and centrifuged. The supernatant was
removed, and the water content was adjusted to ∼80% (w/w), and the suspen-
sion was transferred to NMR tubes.
2.3. CD measurements
CD spectra of the peptides were recorded at room temperature on a Jasco J-725
spectropolarimeter (Jasco, Japan) using a 1-mm-path-length cell. The spectra were
measured between 200 and 250 nm in 20 mMTris buffer (100 mMNaCl, pH 7.6)
or in the presence of 10 mMPOPC SUVs (same buffer) and average blank spectra
were subtracted. Datawere collected at 0.1 nmwith a scan rate of 100 nm/min and a
time constant of 0.5 s. The concentration of the peptides was 50 μM.The helicity of
the peptides, fH, was determined from the mean residue ellipticity [Θ] at a wave-
length of 222 nm according to the empirical method of Rohl and Baldwin [28].
2.4. High-sensitivity titration calorimetry
Isothermal titration calorimetry was performed using a MicroCal VP high-
sensitivity titration calorimeter (MicroCal, Northampton, MA) according to
Wiseman et al. [29]. To eliminate air bubbles, solutions were degassed under
vacuum prior to use. The calorimeter was calibrated electrically. The data were
acquired by computer software developed by MicroCal. In control experiments,
the corresponding peptide solution (or vesicle suspension) was injected into
buffer (20 mM Tris–HCl, 100 mM NaCl, pH 7.6). Heats of dilution were
subtracted from the actual measurement.of Oxki1 and Oxki2. Charged, neutral, and hydrophobic residues are shown in
Fig. 2. CD spectra of synthetic Oxki1 and Oxki2 in 20 mM Tris–HCl buffer plus
10 mM POPC SUVs, pH 7.6.
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All solid-state NMR spectra were acquired on a CMX Infinity 300 spec-
trometer (Chemagnetics, Varian, Palo Alto, CA) operating at a proton resonance
frequency of 300 MHz. 31P spectra were acquired using a 5-μs single excitation
pulse with 30-kHz continuous wave (CW) 1H decoupling during acquisition.
The dwell time was 50 μs, and 100–2000 transients were accumulated for each
free induction decay (FID) with a 3-s relaxation delay. The 31P chemical shifts
were referenced externally to 85% H3PO4 (0 ppm).
3. Results
3.1. Circular dichroism
CD spectroscopy was used to study the secondary structures
of Oxki1 and Oxki2. Fig. 2 shows the CD spectra of both
peptides in the presence of 20 mM Tris–HCl buffer plus 10 mMFig. 3. Titration calorimetry of the binding of Oxki2 to POPC SUVs. (a) Calorimeter t
(1.4266 ml) containing 15 mM POPC SUVs. (b) The heat of reaction of the experim
POPC SUVs suspension in the reaction cell containing a 6 μM peptide solution. (d)POPC SUVs. The CD spectra indicated the formation of α-
helical structures with double minima around 208 and 222 nm.
The helicity of the peptides, fH, determined from the mean res-
idue ellipticity at 222 nm, [Θ]222, was found to be 29.3% for
Oxki1 and 21.3% forOxki2. Similar CD spectra of the oxyopinins
have been previously observed in 60% solutions of TFE, a solvent
that mimics hydrophobic environments [27]. In the presence of
20 mM Tris–HCl buffer, the oxyopinins adopted unordered
structures (spectra not shown).
3.2. Binding enthalpy measured with isothermal titration
calorimetry
We have used high-sensitivity calorimetry to investigate the
binding of oxyopinins to phospholipid vesicles. Fig. 3a shows a
4-μl step titration of 200 μM Oxki2 peptide solution into a
suspension of 15 mM POPC SUVs at 30 °C. Since the heat of
reaction (hi) was virtually identical in each 4-μl injection, it was
concluded that the injected peptide was completely bound to the
POPC vesicles (Fig. 3b). The average heat of injection was
−12.4 μcal. As a control, the same peptide solution was injected
into a buffer solution (data not shown), yielding a heat of dilution
of −0.4 μcal. This was subtracted from the actual measurement,
yielding an average heat of reaction of δh=−12.0 μcal. The
enthalpy of binding into the POPC membranes was calculated
under the assumption that all injected peptide was completely
bound to the phospholipid vesicles. The enthalpies were −18.1
and −15.0 kcal/mol for Oxki1 and Oxki2, respectively.
Fig. 3c displays a 10-μl step titration of 30 mM POPC SUV
suspension into an Oxki2 peptide solution (cp
0 =6 μM) at 30 °C.
Here, each 10-μl injection gave rise to an exothermic heat of
reaction (hi), which decreased in magnitude with consecutive
injections. As a control, a suspension of 30 mM POPC SUVs
was injected into the buffer solution (data not shown), yielding aracings. A series of 4-μl injections of 200 μMpeptide solution in the reaction cell
ent shown in (a). (c) Calorimeter tracings. A series of 10-μl injections of 30 mM
Cumulative heat of reaction of the experiment shown in panel (c).
Fig. 4. Binding of Oxki2 to POPC SUVs. The bound peptide to lipid
(Xb=mmolOxki2/mol POPC SUVs) is plotted as a function of the free peptide
concentration (cp,f). A 6 μM peptide solution, at 30 °C, was titrated with SUVs.
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actual measurement (Fig. 3d). The cumulative heat of reaction
after i injections according to Eq. (1) is shown in Fig. 3d.
yHi ¼
Xi
k¼1
yhk ð1Þ
The reaction had largely ceased after 20 injections, and all
peptide was bound to the lipid vesicles. The accumulative heat
was δH20=130.0 μcal, and the molar heat of binding, which was
exothermic, wasΔH=δH10/np
0 =−15.2 kcal/mol. This value was
in good agreement with those determined in Fig. 3a and b. Wenk
et al. [30] have shown similar results using ITC experiments to
investigate the binding of magainin 2 amide to phospholipid
vesicles [30]. Moreover, the isothermal titration calorimetry
experiments showed that at low P/L ratio [(P/L)0 =1/27000]
Oxki2 was bound immediately to the POPC vesicles, and that atFig. 5. 31P NMR spectra of dispersions of DEPE in the absence (a) and presence of O
1/100 for panels (b, d) and 1/20 for panels (c, e).high P/L ratio [(P/L)0 =1/35] the binding to POPC vesicles was
completely saturated.
Fig. 4 shows the binding of Oxki2 to POPC SUVs (Xb) as a
function of the free Oxki2 concentration. Although the lipid bi-
layer was composed of neutral POPC phospholipids, the binding
isotherm was linear up to 6 mmol peptide/mol POPC and mem-
branes were saturated at 8 mmol peptide/mol POPC. This can be
explained as follows: Since the binding of the first Oxki2 mole-
cules (which possesses a positive charge) to the neutral mem-
brane creates a positively charged outer surface, the binding of
further molecules becomes more difficult due to the electrostatic
repulsion [31]. The peptide partition coefficient (Kp) was deter-
mined from the slope of the initial, linear portion of the binding
isotherms (Xb), and it was found to be Kp=3.9×10
3 M−1.
3.3. Peptide— DEPE lipid membrane interactions and peptide
induced curvature strain
To examine the effect of Oxki1 and Oxki2 on DEPE lipid
bilayers, and their abilities to induce curvature strain on lipid
bilayers, 31P NMR spectra of DEPE lipid bilayers in the absence
and presence of the oxyopinins were observed at various tem-
peratures under static conditions. Fig. 5a shows the 31P NMR
spectra of DEPE lipid bilayers at various temperatures in the
absence of peptides. At 50 °C, an axially symmetric and mo-
tionally averaged powder pattern was observed. This pattern
indicated that the lipids formed MLVs. When the temperature
was raised to 55 °C, a peak around 6 ppm was observed super-
imposed on the MLV component, indicating the coexistence of
an inverted hexagonal phase [32] and a Lα phase. At 60 and
70 °C, only the inverted hexagonal phase was observed. Since
the Lα-HII phase transition temperature (TH) of DEPE is around
60 °C [33], this temperature dependence was reasonable. In the
presence of Oxki1 (Fig. 5b and c), the spectrum exhibited a
similar MLV phase as in the absence of peptide at 50 °C;
however, the higher the concentration of Oxki1 the higher the THxki1 (b, c) and Oxki2 (d, e) at various temperatures. The peptide/DEPE ratio was
Fig. 7. 31P NMR spectra of E. coli total lipid bilayers in the absence (a) and
presence of Oxki1 (b, c) and Oxki2 (d) at 30 °C. The peptide concentrations
were 0.1 mM for (b) and 1 mM for (c) and (d). Lipid concentrations were
5% w/w.
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curvature strain on the membrane according to Wieprecht et al.
and Wildman et al. [34,35]. Furthermore, in the presence of
Oxki2 (Fig. 5d and e), the temperature dependence of DEPE
showed a higher TH value than that in the presence of Oxki1
under the same peptide/lipid molar ratio, implying that Oxki2
imposed a stronger positive curvature strain on the membrane
than did Oxki1.
3.4. Oxki2-PC lipid membrane interactions
In order to examine the effects of Oxki2 on PC lipidmembranes,
31P NMR spectra of PC lipid membranes in the presence of Oxki2
were measured under static conditions. Fig. 6a shows 31P NMR
spectra of dispersions of DMPC membranes (Tm ∼23 °C) [36] at
30 °C containing various amounts of Oxki2. At P/L=1/100, sharp
isotropic components were observed indicating the coexistence of
an isotropic phase and a Lα phase. At P/L=1/40 and 1/20, only an
isotropic narrow signal was observed. This isotropic component
may be attributed to fast isotopic tumbling of the phospholipids,
which may be caused by the formation of micelles, small
unilamellar vesicles or small discoidal bilayers. A similar sharp
isotropic peak was observed on the DPPC membrane in the
presence of Oxki2 at 50 °C (Tm ∼42 °C) [36] at a molar ratio of
Oxki2/DPPC=1/20 (spectrum not shown). Fig. 6b shows the 31P
NMR spectrum of dispersions of DMPC/DMPG (4:1) membranes
at 30 °C containing Oxki2 at P/L=1/20. No isotropic components
were observed, indicating that micellization was prevented due to
the negatively charged DMPG. The head groups of DMPG most
likely interacted with the positively charged lysine or arginineFig. 6. Effect of Oxki2 at various concentrations and temperatures on the 31P
NMR spectra of phospholipid dispersions composed of (a) DMPC, (b) DMPC/
DMPG (4:1), and (c) POPC.residues in Oxki2. Fig. 6c shows the 31P NMR spectrum of
dispersions of POPC lipid bilayers at 20 °C (Tm ∼−5 °C) [37]
containing Oxki2 at P/L=1/20. Although a small isotropic signal
was observed superimposed on a bilayer component, it was much
smaller than that of Fig. 6a. Also, almost all part of the spectrum
showed an MLV component, suggesting that micellization was
prevented due to the cis-double bond present in the hydrocarbon
chain of POPC.
3.5. Oxyopinins and bacterial membrane interactions
To investigate the effects of the oxyopinins on bacterial
membranes, 31P NMR spectra of E. coli total lipid bilayers were
observed in the absence and presence of Oxki1 and Oxki2. In the
absence of peptides, an axially symmetric motionally averaged
powder pattern was observed (Fig. 7a). When Oxki1 was added
to the bilayers, an isotropic peak was observed at a peptide
concentration of 1 mM (Fig. 7b and c). However, when Oxki2
was added to the bilayers at 1 mM concentration, no isotropic
peaks were observed, and only the axially symmetric and mag-
netically aligned powder pattern was present (Fig. 7d). These
results suggest that Oxki1 is more disruptive to bacterial mem-
branes than Oxki2.
4. Discussion
The CD spectra of Oxki1 andOxki2 (Fig. 2) showed that both
peptides adopt an α-helical structure in lipid membranes. The
enthalpic contribution of helix formation at the membrane sur-
face of POPC/POPG (3:1) SUVs had been estimated previously
by Wieprecht et al. asΔHhelix=−0.72 kcal/mol [38]. According
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binding process is defined by the equation (ΔHhelix) (number
of residue) (helicity); therefore, for oxyopinins were (−0.72)×
48×0.293=−10.1, and (−0.72)×37×0.213=−5.7 kcal/mol for
Oxki1 and Oxki2, respectively. The helix formation accounts for
56% and 38% of the total binding enthalpy of these peptides
(ΔHOxki1=−18.1 kcal/mol andΔHOxki2=−15.0 kcal/mol). The
enthalpic contribution of helix formation and its percent of
contribution to total binding for magainin 2 amide is −12.2 kcal/
mol and 77% [38], for mellitin −13.7 kcal/mol and 77% [38],
and for MSI-843 −2.6 kcal/mol and 60% [39], respectively.
Comparing these values with those found for oxyopinins, the
enthalpic contribution of helix formation was smaller for the
oxyopinins, and thismay be attributed to the low helicity ofOxki1
and Oxki2 as shown by the CD spectra. The non-helix contribu-
tion toΔH (ΔH0) was then −8.0 kcal/mol and −9.3 kcal/mol for
Oxki1 and Oxki2, respectively. These valuesmight be due to pore
formation and disintegration of the peptides [30].
In neutral POPC membranes, the partition coefficient for
Oxki2 was 3.9×103 M−1, which suggest that Oxki2 interacts
weakly. In neutral POPC membranes, the partition coefficient
for polyphemusin, an antimicrobial peptide, was 2.7×103 M−1
[26], and that for Cyclosporin A, an immunosuppressive agent,
was 4.3×103 M−1 [31]. On the other hand, in negatively charged
POPC/POPG (3:1) membranes, the partition coefficient for
polyphemusin was 31×103 M−1 [26]. Comparing these values,
the low affinity of Oxki2 for neutral POPCmembranes is similar
to other antimicrobial agents, and Oxki2 might show greater
affinity to negatively charged membranes.
The 31P NMR spectra of DEPE membranes (Fig. 5) sug-
gested that both Oxki1 and Oxki2 induced positive curvature
strain in lipid bilayers. Belokoneva et al. [40] reported that the
Oxki1-induced calcein release from PC SUVs was significantly
inhibited by the incorporation of PE, a negative curvature
inducer, into the PC calcein-loaded SUVs. These results indi-
cated that the positive curvature favored pore formation by
Oxki1. Similarly, magainin2 is known to form toroidal pores,
which are caused by positive curvature stress induced by the
peptide on lipid membranes [41,42]. Therefore, it seems that
Oxki1 and Oxki2 are likely to form toroidal pores by inducing
positive curvature strain in lipid membranes, as does magainin 2.
Brown [43] mentioned that the change in the curvature in
lipid bilayers could be caused for a conformational change of
proteins, as in the case of the conformational change of rhodop-
sin from MI to MII state. In rhodopsin, the MI state favored the
lamellar phase with zero spontaneous curvature; on the other
hand, elongation or protrusion of rhodopsin at the MII state
induce the reverse hexagonal (HII) phase with a negative in-
terfacial curvature in lipid bilayers. Similarly, the presence of
oxyopinins may induce the imbalance of attractive and repulsive
force at the level of the lipids head group and acyl chains in lipid
bilayers; and then, they form the non-lamellar phase with a
positive interfacial curvature of lipid bilayer, which might be at a
free energy minimum in lipid–membrane peptide interaction.
The 31P NMR spectra of DMPC membranes (Fig. 6) in the
presence of Oxki2 showed that Oxki2 promotes micellization of
membranes. On the other hand, the micellization by Oxki1 andOxki2 did not occur on DEPE membranes (Fig. 5) suggest-
ing that the negative curvature of DEPE membranes prevented
micellization by the oxyopinins. These results are strongly cor-
related to the biological activity of both peptides [27]. It was
observed that the hemolytic and pore-forming activities of
Oxki1 and Oxki2 depend on the source of red blood cells, which
were strongly associated with the percentages of PC in the total
membrane phospholipids of 41, 23, and 1% for Guinea pig, pig,
and sheep red blood cells, respectively [44,45]. The hemolytic
and pore-forming activities of Oxki1 and Oxki2 were higher in
Guinea pigNpigN sheep [11]. Thus, erythrocytes having PC-
rich cell membranes are more susceptible to the hemolysis in-
duced by the oxyopinins. Furthermore, Oxki1 and Oxki2 were
more lytic toward PC vesicles than towards PE and PA [11]. The
pore-forming activities of oxyopinins may be explained by their
abilities to induce positive curvature strains in lipid bilayers.
Cholate molecules are also known to disrupt lipid membranes
by a strong ability to induce a positive curvature strain in lipid
bilayers [46]. Thurmond et al. [46] reported that cholate changes
the curvature of DOPE from negative (HII phase), through zero
(Lα phase) and finally to a phase of positive curvature (micellar
solution) at high water content. The cholate molecule consists of
a rigid steroid fused ring system, which is roughly planar, in
which one side is hydrophobic and the other one is hydrophilic.
The strong ability to induce the positive curvature strain was
explained in terms of its unique structure, which have tendency
to lie flat on the lipid aggregate surface and increase the effective
interfacial area of the polar head groups. Although oxyopinins
do not have such rigid ring system, they might lie on the lipid
membrane due to basic and acidic amino acid-rich character, and
it may be the reason for their strong ability to induce positive
curvature.
E. coli total lipid contains (w/w) approximately 57.5% PE,
15.1% PG, 9.8% Cardiolipin, and 17.6% other lipids [47,48].
Moreover, it was reported that Oxki1 kills E. coli cells at lower
concentrations than that of Oxki2 [27]. The fact that Oxki1
showed stronger antimicrobial activity towardE. coli than Oxki2
also correlates to our NMR results in Fig. 7. Therefore, the
stronger antimicrobial activity of Oxki1 may also originate from
the stronger ability of Oxki1 to disrupt bacterial membranes.
The typical “toroidal pore” forming antimicrobial peptides,
PGLa (GMASK AGAIA GKIAK VALKA L-NH2)[1] and
magainin 2 (GIGKF LHSAK KFGKA FVGEI MNS)[2], do not
have tryptophan and tyrosine residues. These residues are known
to reside preferentially near the membrane surface [49]. There-
fore, the ability to induce positive curvature strain of oxyopinins
might be due to the absence of the amino acid residues tryptophan
and tyrosine. Furthermore, the stronger ability of Oxki2 to induce
a positive curvature strain might be due to the absence of a central
proline residue. For example, the transmembrane type peptides,
melittin and pandinin 2, have a proline residue in the middle of
the alpha-chain. On the other hand, “toroidal pore” forming
antimicrobial peptides, PGLa and magainin 2, have no proline
residue. Kobayashi et al. had reported that a Pro→Ala sub-
stitution in buforin 2 (TRSSR AGLQW PVGRV HRLLR K)[3]
caused buforin 2 to show magainin-like properties in terms of
conformation, translocation efficiency, and leakage coupled lipid
1481K. Nomura, G. Corzo / Biochimica et Biophysica Acta 1758 (2006) 1475–1482flip-flop [50]. Therefore, a central proline residue could be a very
important factor for curvature strains induced by these antimi-
crobial peptides.
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